Reactivation of Chlamydia trachomatis lung infection in mice by cortisone.
To study the latency, chronicity, and recurrent nature of chlamydial infection, we attempted to reactivate Chlamydia trachomatis lung infection in mice by immunosuppressive therapy with cortisone. Mice were treated with subcutaneous injections of cortisone acetate (125 mg/kg) every other day, starting on day 14 after intranasal inoculation of C. trachomatis serotype B (TW-5). C. trachomatis was recovered from the lungs beginning day 6 after the start of cortisone treatment until the end of the observation period on day 12 of treatment. Overall, the reactivation was successful in 8 of 55 mice treated with cortisone, in contrast to 0 of 41 inoculated, untreated mice (P = 0.009) and 0 of 35 uninoculated, treated mice. Cortisone treatment affected the ability of peritoneal exudate cells to respond to migratory inhibition after exposure to purified whole organisms of C. trachomatis serotype B (TW-5) but had little effect on serum antibody titers, indicating a possible role for cellular immunity in resistance against C. trachomatis infection in the lung.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D002464:Cell Migration Inhibition; D002690:Chlamydia Infections / Q000276:immunology* / Q000473:pathology; D002692:Chlamydia trachomatis / Q000276:immunology; D003348:Cortisone / Q000031:analogs & derivatives* / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008168:Lung / Q000473:pathology; D051379:Mice; D011014:Pneumonia / Q000276:immunology* / Q000473:pathology; D012008:Recurrence
D000907:Antibodies, Bacterial; D007166:Immunosuppressive Agents; D003348:Cortisone